Simulations Plus Inc. | Cash Flow

Fiscal year is September-August. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,886.60
3,025.50
3,843.00
4,950.10
5,787.60
8,934.80
Depreciation, Depletion & Amortization
767.00
1,037.40
1,989.60
1,932.30
2,135.10
2,721.30
Other Funds
70.80
-
750.00
750.00
1,000.00
861.80
Funds from Operations
4,065.50
5,506.20
6,183.70
7,206.30
8,404.30
10,786.10
Changes in Working Capital
1,503.10
200.00
951.30
1,791.10
1,526.50
1,498.90
Net Operating Cash Flow
2,562.40
5,306.20
7,135.00
5,415.20
6,877.70
9,287.20
Capital Expenditures
1,181.70
3,893.60
1,240.30
1,235.00
1,559.70
Sale of Fixed Assets & Businesses
-
-
190.20
-
1,720.40
Net Investing Cash Flow
1,181.70
3,893.60
3,130.10
1,955.00
4,355.20
Cash Dividends Paid - Total
4,001.20
3,075.60
3,375.60
3,413.30
3,448.50
Net Financing Cash Flow
3,902.40
2,977.00
4,068.50
3,981.20
4,337.10
Net Change in Cash
2,521.80
1,564.40
63.70
521.00
1,814.60
Free Cash Flow
2,509.20
5,281.70
7,063.60
5,376.10
6,701.80
Deferred Taxes & Investment Tax Credit
367.00
1,298.90
55.90
23.20
178.40
1,731.80
Net Assets from Acquisitions
-
-
2,080.00
720.00
4,516.00
Change in Capital Stock
28.00
98.60
57.00
182.00
111.40

About Simulations Plus

View Profile
Address
42505 10th Street West
Lancaster California 93534
United States
Employees -
Website http://www.simulations-plus.com
Updated 07/08/2019
Simulations Plus, Inc. engages in licensing and conducting drug research by pharmaceutical and biotechnology companies. Its services include consulting services, modeling and analysis or simulation, pharcometric data assembly, and training and workshops. The company was founded by Walter S.